Pharmaceutical Technology
OCTOBER 15, 2024
Pharmaceutical giants cannot work in a silo to reach net zero. Pharma contract manufactures have a duty to engage with the science-based climate targets, says ACG.
AuroBlog - Aurous Healthcare Clinical Trials blog
OCTOBER 15, 2024
(Abdullah Durmaz/Getty Images) In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as billion-dollar annual sellers for weight loss as well as to control blood sugar levels and reduce the risk of heart disease.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
OCTOBER 15, 2024
Lundbeck is to acquire Longboard for $2.6bn equity value in a move set to enhance its capabilities within neuro-rare conditions.
pharmaphorum
OCTOBER 15, 2024
Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster.The Danish drugmaker has offered $60 per share for California biotech Longboard, with the main asset in the deal bexicaserin, an oral, centrally acting serotonin 5-HT 2C receptor super-agonist in late-stage testing for seizures associated with rare forms of epilepsy.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Pharmaceutical Technology
OCTOBER 15, 2024
Huawei hosted GITEX's Industrial Digital and Intelligent Transformation Summit and launched joint solutions with partners for ten industries.
Bio Pharma Dive
OCTOBER 15, 2024
The amount surpassed the firm’s targets, allowing it to increase the size and number of company financings it plans to do in the future.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Bio Pharma Dive
OCTOBER 15, 2024
The pharma will work with Triana Biomedicines on molecular glue degraders. Elsewhere, Akeso raised $250 million and a MASH drug developer got a well-known board chair.
Pharma Times
OCTOBER 15, 2024
Partnership to harness AI for DUB-focused preclinical programmes
Bio Pharma Dive
OCTOBER 15, 2024
Biosimilar competition is expected in early January for the company’s second highest-selling drug, putting greater focus on newer products' market trajectory.
Pharmaceutical Technology
OCTOBER 15, 2024
Despite this setback, Transgene plans to explore the potential benefits of the vaccine in specific patient populations.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
OCTOBER 15, 2024
GSK has filed lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and RSV
Pharmaceutical Technology
OCTOBER 15, 2024
Bayer notches up pressure on rival Astellas’ Veozah with an EU marketing authorisation application for its hot flash relief pill.
pharmaphorum
OCTOBER 15, 2024
Transgene's therapeutic vaccine for cervical and anogenital cancers failed a phase 2 trial, but an efficacy signal warrants further study
Pharmaceutical Technology
OCTOBER 15, 2024
Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last year, Lilly hopes to introduce Omvoh as its competitor.
pharmaphorum
OCTOBER 15, 2024
Health plans, employers, and healthcare providers plan to increase their spending on digital health technologies in the next 12 months, says PHTI survey
Pharmaceutical Technology
OCTOBER 15, 2024
The agreement will see MEDiC’s MCAT platform identify biomarkers to support the development of Hanmi’s clinical assets.
Drug Patent Watch
OCTOBER 15, 2024
Have you ever found yourself scratching your head at the pharmacy counter, wondering why your “3-month supply” of medication doesn’t quite match up with the calendar? You’re not alone. Many people are puzzled by the discrepancy between a 92-day supply of pills and the actual number of days in a three-month period.
Pharmaceutical Technology
OCTOBER 15, 2024
digital twins can be used to progress healthcare, drug development, and research by enabling the delivery of personalised medicine.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Outsourcing Pharma
OCTOBER 15, 2024
The big pharma company Sanofi has discontinued a phase 2 trial of U.S. partner Denali Therapeuticsâ oditrasertib for the treatment of multiple sclerosis after the drug failed to perform.
Pharmaceutical Technology
OCTOBER 15, 2024
In pharmaceutical manufacturing, viscous drug products pose unique challenges to filling efficiency and accuracy.
pharmaphorum
OCTOBER 15, 2024
Germany is the first market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema
Pharmaceutical Technology
OCTOBER 15, 2024
Boehringer Ingelheim, in partnership with the WHO Foundation, has committed $5m to enhance healthcare access.
BioPharma Reporter
OCTOBER 15, 2024
MilliporeSigma has unveiled a large new biosafety testing facility in Rockville to meet the global demand.
Pharmaceutical Technology
OCTOBER 15, 2024
Discover the leading Parenteral Solutions in Pharmaceutical Contract Manufacturing. Download the free Buyer's Guide for full contact details.
pharmaphorum
OCTOBER 15, 2024
mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment.
My Local Study
OCTOBER 15, 2024
Diversity in clinical trials is critical for ensuring that medical treatments are safe and effective for everyone, regardless of race, gender, age, or socioeconomic background. Historically, certain groups have been underrepresented in clinical research, leading to gaps in knowledge about how treatments affect different populations. Increasing diversity in clinical trials is essential to creating more.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Drug Channels
OCTOBER 15, 2024
A new survey of plan sponsors sheds light on their satisfaction with transparency at large and small pharmacy benefit managers (PBMs). As you will see, clients remain slightly more satisfied with the perceived transparency of smaller PBMs compared with the Big Three PBMs—CVS Caremark, Express Scripts, and Optum Rx. However, plan sponsors are dissatisfied with transparency about how both large and small PBMs make money.
BioPharma Reporter
OCTOBER 15, 2024
The approval of Hympavzi makes it the first treatment for both hemophilia A and B to be administered through a pre-filled pen or syringe.
Fierce Pharma
OCTOBER 15, 2024
Jazz Pharmaceuticals’ Zepzelca, once on the brink of a market withdrawal, has returned with new trial results showing it could prolong patients’ lives in extensive-stage small cell lung cancer (ES- | Jazz Pharmaceuticals’ Zepzelca, once on the brink of a market withdrawal, has returned with new trial results showing it could prolong patients’ lives in extensive-stage small cell lung cancer.
pharmaphorum
OCTOBER 15, 2024
Explore key forecasting considerations throughout the pharmaceutical product lifecycle, from the preclinical stage to Phase III and launch. Understand how to optimise forecasting strategies for each stage effectively.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expert insights. Personalized for you.
130 
Let's personalize your content